Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. - Wikidata - awgldk - TriplyDB

Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor.

Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor.

http://www.wikidata.org/entity/Q34245963

about

Recent advances in understanding hepatitis C Entry inhibitors: New advances in HCV treatment Host restriction factors for hepatitis C virus Roles of lipoprotein receptors in the entry of hepatitis C virus Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection Chronic hepatitis C virus infection and lipoprotein metabolism Hepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagy Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design Curing a viral infection by targeting the host: the example of cyclophilin inhibitors New hepatitis C virus drug discovery strategies and model systems Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization Murine models of hepatitis C: what can we look forward to?Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases Direct acting antivirals for the treatment of chronic viral hepatitis ABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus Production Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets The impact of hepatitis C virus entry on viral tropism Intracellular autofluorescence: a biomarker for epithelial cancer stem cells Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes Comparative Proteomics Reveals Important Viral-Host Interactions in HCV-Infected Human Liver Cells The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study Advanced molecular surveillance of hepatitis C virus Recent advances in hepatocellular carcinoma therapy.Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.Recombinant hepatitis C virus-envelope protein 2 interactions with low-density lipoprotein/CD81 receptors.Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Occult infection with hepatitis C virus: friend or foe?Advancement in the development of models for hepatitis C research.Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis.Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission The missing pieces of the HCV entry puzzle.Regulated Entry of Hepatitis C Virus into Hepatocytes.Protective immunity against hepatitis C: many shades of gray.Inhibitors of the tick-borne, hemorrhagic fever-associated flaviviruses.A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2 Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle

P2860

Q26766136-45548E69-EDB6-4AB1-983E-8AE8D07A6A8D Q26770817-D2E7F962-716B-480C-99BF-C129D3AD6469 Q26773258-D3B65B50-0D23-47D5-98DB-B4EEF8BE2171 Q26777338-4FD18AF2-B7EA-4E97-90EA-405862D20CA9 Q26779128-74119618-F44D-4805-8581-4EEDBCE05523 Q26784234-2CA4FA76-78ED-424E-A3EB-6EE52E71E96A Q26801207-ABB63FCB-7057-4C8B-A4B3-682306595FED Q26801759-60B65D66-A508-492A-9F2D-B1BB9D219B89 Q26828727-B24C20A9-2394-4FE4-AD84-7A8F8A482AE8 Q26851159-951AED32-F3FA-43FD-8C1E-B473FD3A261B Q26853500-5548AD0B-A257-497C-B896-4C5C4CD97DD0 Q26864485-67BDC308-945D-4B72-BD0A-5F98F30EF8D2 Q26991875-4F634B8D-AA0C-4AF8-AAF2-57A23882EB03 Q26992256-0850BDC6-D120-47FA-8F54-677205C0E0EC Q27022216-50EEDAA5-3EBD-41EF-9F8E-E22E7E686A16 Q27314827-24AFB2E2-2EB0-4353-860B-D3D030282A59 Q27468855-0BAD0B65-3DF7-4619-A2D1-A89A261F0E59 Q27693297-54DF981C-84DF-4BB7-9713-D309503AECB0 Q28049473-8EB3A249-4F38-43CA-A572-BEBCC316BDCC Q28081216-D2832D11-9665-410C-BD09-CF61C1E3441A Q28115022-739B5164-EF07-48C1-9701-82E5E45DF596 Q28271798-878B946F-53ED-41DF-B256-973480852042 Q28482494-2C007667-82CB-4226-8762-6F5230725A0A Q28488372-6F1EC8C0-5936-4CEF-B351-3D14036DC8A3 Q28550969-2B6B8F92-C2DC-4FE5-8CFE-B8F518EECC18 Q28650908-0575DB1C-CC8C-46C2-970D-7F55AA64BA9C Q30236010-EC75984F-B18D-4748-9FD5-301607CCAE77 Q30364309-0C372D3E-38E7-43C8-8EDE-89D705AE310A Q30375044-7710FE3D-90D3-43D1-94C9-02E47424E5BD Q30386551-B9BF9009-D004-44D9-9342-120BA51C2F39 Q30416187-BE8140A5-297D-44FC-9C76-480995038B21 Q30418069-3A51700F-1AC1-4C1F-8FD0-2ECA8DEA33B0 Q30531290-21B36234-27B8-4428-997D-A6F5217A6FA6 Q30541733-60C4F517-882E-4FEB-9B41-C59A61B5BEA0 Q33360674-4C0665A7-0AB2-4CB8-8D7F-2529F66A635B Q33753913-1CB6458B-B3BA-4906-B47E-99E423474A11 Q33759224-4117F4A7-310F-4E37-8B0A-97DEFFFC1139 Q33798180-AEED332E-7B45-4799-A6B1-CCE328D5F41C Q33822543-33614D7D-F56A-466A-9986-42DC8741B278 Q33893794-E8E94C71-D259-40A3-8597-B3BF63B965F7

P2860

Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor.

http://www.wikidata.org/entity/Q34245963

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Identification of the Niemann- ...... epatitis C virus entry factor.

@ast

Identification of the Niemann- ...... epatitis C virus entry factor.

@en

Identification of the Niemann- ...... epatitis C virus entry factor.

@nl

type

label

Identification of the Niemann- ...... epatitis C virus entry factor.

@ast

Identification of the Niemann- ...... epatitis C virus entry factor.

@en

Identification of the Niemann- ...... epatitis C virus entry factor.

@nl

prefLabel

Identification of the Niemann- ...... epatitis C virus entry factor.

@ast

Identification of the Niemann- ...... epatitis C virus entry factor.

@en

Identification of the Niemann- ...... epatitis C virus entry factor.

@nl

P1433

Q34245963-08CCCE26-590D-4573-BE50-3CE41B38310E

P1476

Q34245963-3E80E46D-3FCF-40AC-ACE4-4BD6201D8048

P2093

Q34245963-02A6AEC7-AE89-45A0-B8E5-0D11D6FAA5F6

Q34245963-10B0E01F-E9EF-4CD6-9E25-CEF026BE9FA4

Q34245963-1E04999D-9EB8-4BAD-873D-EB9878C09D97

Q34245963-1F379423-4604-4A9A-8AF1-68F15A0B8112

Q34245963-45A2DC77-F5B2-4C27-95F2-19E3EC05DFBD

Q34245963-6BB085FC-A66A-4C01-8A1E-1E496FCDBDFB

Q34245963-9A57B145-EDD3-41D5-8C32-D3B0E43DA0E3

Q34245963-C4578436-B883-4EFC-BCB5-C3F214EDF833

Q34245963-D37FDE19-E103-443D-A8A9-FE96BB413203

Q34245963-EACF2F69-7379-474B-8CCA-96B67B445E80

P2860

Q34245963-02B5F8A4-2EF9-428D-8120-FC1E180C732E

Q34245963-0B7B8EEE-4613-4CD6-A82F-C3879FD82F60

Q34245963-0E381E78-30E8-41DF-A5D7-C721040AB695

Q34245963-2A5F5F44-7B23-4BC7-ADBD-7F9F2CCC5D51

Q34245963-3EE3A9A0-241D-4E5A-AC22-270266A6C33D

Q34245963-3FA39A77-65BE-4D91-8E0E-91F6A3474621

Q34245963-42CC4781-1A47-42FE-B03C-6FFC20AA9540

Q34245963-4386CD35-5E9E-4B93-ACAA-B66ED1AD6FAA

Q34245963-4A271EE9-724B-402A-BE81-F4D75B828F28

Q34245963-4E737636-9D1D-485D-A8E4-91480ACF2679

P2888

Q34245963-CDFFB7B3-87D1-42D2-862A-6209AF2BB3FD

P304

Q34245963-12B65EB1-AEE9-4797-AD74-FEF829799DF0

P31

Q34245963-21168682-072E-472E-843E-3EB4A56CFC12

P356

Q34245963-631A4A25-C0ED-4404-8F4D-CD6972C798E5

P407

Q34245963-CE1EAD46-AF6E-420C-994D-437647BE4C6C

P433

Q34245963-86BCC68C-7FD2-4509-8222-D31576C38A00

P478

Q34245963-7E6F4914-2F58-4642-B4CE-FA3F9D861CAB

P577

Q34245963-7BB06025-D0C0-4668-9C1F-1C7583593227

P5875

Q34245963-2BBAEC47-0BE8-45ED-9284-F77EAE948C15

P6179

Q34245963-75B16D12-DB63-43F3-98B9-A05568FE1F21

P698

Q34245963-B5687914-12DB-4570-8D5E-FB8ED031107A

P932

Q34245963-5DCE99E1-6DFA-47C5-B65D-7551EFAA1284

P356

P1433

Nature Medicine

P1476

Identification of the Niemann- ...... epatitis C virus entry factor.

@en

P2093

Bruno Sainz

http://www.w3.org/2001/XMLSchema#string

Danyelle N Martin

http://www.w3.org/2001/XMLSchema#string

Katherine A Marsh

http://www.w3.org/2001/XMLSchema#string

Kazuaki Chayama

http://www.w3.org/2001/XMLSchema#string

Michio Imamura

http://www.w3.org/2001/XMLSchema#string

Naina Barretto

http://www.w3.org/2001/XMLSchema#string

Nobuhiko Hiraga

http://www.w3.org/2001/XMLSchema#string

Snawar Hussain

http://www.w3.org/2001/XMLSchema#string

Susan L Uprichard

http://www.w3.org/2001/XMLSchema#string

Waddah A Alrefai

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I

Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry

Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus and Host

Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles

Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins

Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion

Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection

P2888

P304

281-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.2581

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221735047

http://www.w3.org/2001/XMLSchema#string

P6179

1032636814

http://www.w3.org/2001/XMLSchema#string

P698

22231557

http://www.w3.org/2001/XMLSchema#string

P932

3530957

http://www.w3.org/2001/XMLSchema#string